DVA vs PVLA · P/E 14, rev $6.97B vs $1.64B cap
DaVita HealthCare Partners Inc (DVA) versus Palvella Therapeutics, Inc (PVLA) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Palvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
PVLA does not have a complete income-statement cache yet.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. PVLA currently screens at market cap $1.64B.
Not investment advice. Open the DVA and PVLA stock pages for the full models.
Not investment advice.